PA
ARNA

Profund Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Profund Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,177
Closed -$17K – 1495
2017
Q1 		$17K Sell
1,177
-143
-11% -$2.12K ﹤0.01% 1463
2016
Q4 		$19K Buy
1,320
+164
+14% +$2.54K ﹤0.01% 1546
2016
Q3 		$20K Buy
+1,156
New +$19.2K ﹤0.01% 1420
2014
Q3 		– Sell
-14,651
Closed -$859K – 1479
2014
Q2 		$859K Sell
14,651
-3,454
-19% -$217K 0.04% 569
2014
Q1 		$1.14M Buy
18,105
+3,628
+25% +$241K 0.05% 399
2013
Q4 		$847K Buy
14,477
+3,048
+27% +$159K 0.04% 635
2013
Q3 		$602K Buy
11,429
+419
+4% +$28.1K 0.03% 803
2013
Q2 		$848K Buy
+11,010
New +$899K 0.06% 335

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Profund Advisors's ARNA Position: Q2 2017 in Review

Profund Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2017, closing a stake of 1,177 shares — an estimated $17K sold.

Profund Advisors first reported a position in ARNA in Q2 2013 and held it in 8 quarters. The position peaked at $1.14M in Q1 2014. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Profund Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Profund Advisors sold 1,177 Arena Pharmaceuticals Inc shares in Q2 2017, an estimated $17K.
  • Profund Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
  • Profund Advisors's Arena Pharmaceuticals Inc position peaked at $1.14M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Profund Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.